Internal Medicine, Hematology & Oncology · Toledo, OH
NPI
1013975903
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1325 Conference Dr Ste 2010
Toledo, OH, 43614
Phone (419) 383-6644
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
319,353 services
Medicare patients, 2024
809
Average age 75
Drug cost, 2024
$7.3M
2,334 prescriptions
Company payments, 2025
$226
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy C Kasunic was code J1439 (injection, ferric carboxymaltose, 1 mg), 63,750 times for 59 patients. In total Timothy C Kasunic billed 319,353 services in 146 codes, and Medicare paid $4.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 63,750 | 59 | $0.87 | $56K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 39,000 | 11 | $0.22 | $8,696 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 22,440 | 27 | $0.29 | $6,487 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,400 | 26 | $44.13 | $812K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,540 | 17 | $39.36 | $376K |
| J0897 Injection, denosumab, 1 mg | Office | 8,100 | 65 | $20.57 | $167K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 7,360 | 16 | $35.89 | $264K |
| J0185 Injection, aprepitant, 1 mg | Office | 5,980 | 20 | $1.35 | $8,059 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,658 | 11 | $0.08 | $451 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,085 | 77 | $0.09 | $278 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,820 | 23 | $6.19 | $17K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,820 | 11 | $5.74 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,360 | 38 | $0.78 | $1,065 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 1,120 | 14 | $1.38 | $1,541 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 725 | 11 | $0.23 | $165 |
By year: 2022 $3.1M for 230,790 services; 2023 $3.7M for 284,883 services; 2024 $4.8M for 319,353 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy C Kasunic prescribed most often to Medicare patients was Anastrozole, with 245 prescriptions and refills. In total Timothy C Kasunic wrote 2,334 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 245 | 523 | 74 | $6,932 |
| Prednisone Generic | 162 | 196 | 37 | $1,112 |
| Acyclovir Generic | 161 | 285 | 49 | $2,801 |
| Abiraterone Acetate Generic | 120 | 126 | 18 | $121K |
| Prochlorperazine Maleate Generic | 117 | 117 | 70 | $1,749 |
| Eliquis Apixaban | 111 | 150 | 24 | $84K |
| Venclexta Venetoclax | 100 | 101 | 16 | $1.2M |
| Ibrance Palbociclib | 93 | 94 | 11 | $1.4M |
| Letrozole Generic | 76 | 182 | 21 | $1,196 |
| Dexamethasone Generic | 60 | 73 | 31 | $1,366 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 49 | 50 | 34 | $463 |
| Gabapentin Generic | 43 | 59 | 18 | $456 |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $591K |
| Famotidine Generic | 40 | 56 | 14 | $466 |
| Ondansetron Odt Ondansetron | 33 | 33 | 23 | $784 |
Brand drugs: - claims; generic drugs: 1,685 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy C Kasunic $226 ($226 in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Biotech, Inc. with $99.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.